Australia markets closed
  • ALL ORDS

    7,674.20
    +54.00 (+0.71%)
     
  • ASX 200

    7,362.00
    +50.30 (+0.69%)
     
  • AUD/USD

    0.7425
    +0.0004 (+0.06%)
     
  • OIL

    82.66
    +1.35 (+1.66%)
     
  • GOLD

    1,768.10
    -29.80 (-1.66%)
     
  • BTC-AUD

    83,032.30
    +2,587.34 (+3.22%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • AUD/EUR

    0.6396
    +0.0002 (+0.03%)
     
  • AUD/NZD

    1.0486
    -0.0054 (-0.52%)
     
  • NZX 50

    13,012.19
    -36.30 (-0.28%)
     
  • NASDAQ

    15,146.92
    +94.50 (+0.63%)
     
  • FTSE

    7,234.03
    +26.32 (+0.37%)
     
  • Dow Jones

    35,294.76
    +382.20 (+1.09%)
     
  • DAX

    15,587.36
    +124.64 (+0.81%)
     
  • Hang Seng

    25,330.96
    +368.37 (+1.48%)
     
  • NIKKEI 225

    29,068.63
    +517.70 (+1.81%)
     

U.S. administers 390.1 mln doses of COVID-19 vaccines - CDC

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Sept 26 (Reuters) - The United States has administered 390,114,328 doses of COVID-19 vaccines as of Sunday morning and distributed 471,814,235 doses, the U.S. Centers for Disease Control and Prevention said.

The number of doses administered is up from 389,372,689 vaccine doses as reported on Saturday, the CDC said.

However, the number of doses delivered were marginally down from the numbers reported on Saturday. CDC has previously said that revisions made by vaccine providers can result in cumulative delivery data dropping between certain days.

The agency said 213,456,787 people had received at least one dose, while 183,670,870 people were fully vaccinated as of 6:00 a.m. ET on Sunday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech,, as well as Johnson & Johnson's one-shot vaccine

Over 2.66 million people in the United States received an additional dose of either Pfizer or Moderna's vaccine since Aug. 13, when authorities authorized a third dose of the vaccines for people with compromised immune systems who are likely to have weaker protection despite the two-dose regimens. (Reporting by Shubham Kalia in Bengaluru; editing by Grant McCool)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting